Session 32: Stem Cells and Translational Research
R. A. Anderson,M. McLaughlin,D. C. Woods,J. L. Tilly,E. E. Telfer,I. Virant-Klun,M. Stimpfel,B. Cvjeticanin,E. Vrtacnik-Bokal,T. Skutella,C. Beyazyurek,C. G. Ekmekci,N. Gulum,H. A. Tac,S. Kahraman,J. Cheng,J. Su,L. J. Ding,G. J. Yan,Y. L. Hu,S. Hendriks,E. A. F. Dancet,A. Meissner,F. van der Veen,M. H. Mochtar,S. Repping,O. Oktem,M. Muftuoglu,F. Senbabaoglu,B. Urman
DOI: https://doi.org/10.1093/humrep/det165
IF: 6.1
2013-01-01
Human Reproduction
Abstract:Study question: A population of cells termed oogonial stem cells (OSCs) have been identified in human ovaries which may have the potential to develop into oocytes.We have investigated the possibility of isolating OSCs from Turner Syndrome (TS) ovary, and their potential to form oocytes that initiate folliculogenesis in normal ovaries.Summary answer: OSCs were isolated and propagated from TS ovary.After viral transduction with GFP and injection into normal human ovarian tissue we observed formation of follicular structures containing GFP-positive oocytes.OSCs from a normal woman also formed follicles in normal ovary, but neither source of OSCs formed follicles in TS ovary.What is known already: OSCs have been isolated from normal adult human ovary, and when injected into normal ovarian tissue in vitro undergo differentiation to form oocytes, which can subsequently initiate folliculogenesis.Women with TS have a high risk of premature ovarian insufficiency, but some show spontaneous puberty and successful pregnancy is possible.There is the possibility that TS ovary might also contain OSCs with consequences for reproductive potential.Study design, size, duration: This was an in vitro study.DDX4 antibody-based FACS was used to isolate OSCs from ovarian cortex of a normal woman and a teenager with mosaic TS.GFP-expressing OSCs were injected into ovarian tissue, with cross-injection of normal/TS OSCs and normal/TS ovarian tissue, and cultured for up to 3 weeks.Participants/materials, setting, methods: Ovarian tissue was donated for research by 2 young women, one with mosaic TS with regular menstrual cycles.OSCs were isolated, and after GFP transduction were injected into normal and TS human ovarian tissue in vitro and cultured for up to 3 weeks.Immunohistochemistry was used to identify GFP-expressing cells.Main results and the role of chance: Injection of GFP-expressing OSCs from a normal woman into normal ovary results in the appearance of follicular structures containing GFP-positive 'oocytes'.On continued culture, these follicles show growth to multilaminar stages.Culture of TS ovarian tissue resulted in only degenerate secondary follicles.However a population of TS OSCs were isolated, propagated and injected into normal ovarian tissue.After 6 days some TS GFP-positive cells had associated with host somatic cells and were significantly larger than the injected OSCs.These GFP-positive 'oocytes' within follicular structures were identified alongside GFP-negative oocytes in follicles.These TS OSC-derived follicles showed limited development over 3 weeks in culture.Conversely, neither normal nor TS OSCs showed any evidence of oocyte formation or folliculogenesis after injection into TS ovary and culture.Limitations, reason for caution: OSCs have only been isolated from one woman with mosaic TS, which may limit generalisation.Similarly, data on injection of normal OSCs into normal and TS ovary are very limited in this study, but our results with normal human OSCs are in agreement with recent findings (Nat Med 2012 18:413).Wider implications of the findings: These data indicate the need for caution in the potential of conventional ovarian tissue cryopreservation for fertility preservation in young women with TS.It appears that TS ovary contains a population of OSCs, but the ovarian stroma in TS does not support follicle formation.This raises new opportunities for fertility preservation in such cases, although it must be emphasised that the complete developmental potential of these cells has not yet been demonstrated in humans.Study funding/competing interest(s): Study funded by